Guna
Guna is a privately held Italian pharmaceutical company founded in 1983 in Milan, producing low-dose homeopathic medicines and class III injectable collagen medical devices via proprietary SKA technology, distributed through pharmacies, physicians, and exclusive partners in 50+ countries.
- Company typePrivate
- Founded1983
- HeadquartersMilan, Italy
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
What Guna does
Guna S.p.a. is a privately held Italian pharmaceutical company founded in 1983 in Milan by Alessandro Pizzoccaro and Adriana Carluccio, specializing in low-dose homeopathic medicines and class III injectable collagen medical devices. Its core technology is SKA (Sequential Kinetic Activation), a proprietary platform that standardizes the dilution and dynamization process per European Pharmacopoeia standards to produce nano-concentration formulations containing cytokines, hormones, neuropeptides, and growth factors grounded in Psycho-Neuro-Endocrine-Immunology (PNEI) principles. Manufacturing is concentrated in a 64,500+ sq ft GMP-certified facility in Milan (opened 2008) that produces oral medicines (granules, globules, drops, oral sprays, syrups), nasal sprays, and injectable collagen medical devices across seven product categories: Low Dose Medicines, Medical Devices (13 CE-marked class III collagen injectables), Food Supplements/Nutraceuticals, Bach Flowers (with proprietary WHITE Holographic Bioresonance processing), Dermocosmetics, Guna4Pets (animal feed supplements), and Publications (Guna Editore).
The business model is a hybrid B2B/B2C distribution system: in Italy, products flow through the pharmacy network and a field force of pharmaceutical representatives and pharmacy consultants conducting medical detailing to doctors and pharmacists, supplemented by hundreds of educational events annually; internationally, Guna distributes through exclusive local distributors in 50+ countries and operates a wholly-owned US subsidiary (Guna Inc.). Guna also acts as the exclusive Italian distributor for Heel (homotoxicology), Labo'Life (micro-immunotherapy), and Enterosgel. Revenue streams span the seven product categories plus exclusive third-party distribution; pricing is not publicly disclosed but operates on B2B terms through pharmacy and professional channels. The company holds 35% share of the Italian homeopathy market, is self-funded without external equity, and operates under an explicit 'No Patent' policy with copyleft-licensed publications, distinguishing it from typical pharmaceutical IP strategies.
Guna firmographics
Firmographics- Name
- Guna
- Legal name
- Guna S.p.a.
- Website
- https://guna.com
- Company type
- Private
- Founded year
- 1983
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Guna is a privately held Italian pharmaceutical company founded in 1983 in Milan, producing low-dose homeopathic medicines and class III injectable collagen medical devices via proprietary SKA technology, distributed through pharmacies, physicians, and exclusive partners in 50+ countries.
- Ownership category
- akta.pro rank
Guna industry classification
Industry- Product category
- Homeopathic Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Pharmaceutical Preparations (2834), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)
- akta.pro secondary industries
- Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK), Dermatology Specialty Pharmaceuticals (HLAIACAL)
Keywords
Where Guna is headquartered
LocationHeadquarters
- HQ city
- Milan
- HQ country
- Italy
- HQ region
- Europe
Offices2 records
Markets served
Guna business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Personnel, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure
Revenue model
- Low Dose Medicines: Production and distribution of homeopathic and low-dose pharmacological medicines including granules, globules, drops, oral sprays, syrups, and nasal sprays. Core business segment with over 40 years of market presence.
- Medical Devices: CE certified injectable collagen medical devices (class III) for musculoskeletal and aesthetic medicine applications. Includes MD-Knee, MD-Tissue, GUNA Collagen MDs product lines.
- Food Supplements (Nutraceuticals): Physiological nutraceuticals including vitamins, minerals, probiotics, botanical extracts, and specialized formulations for various health needs including digestive health, immune support, and metabolic function.
- Bach Flowers: 38 Bach Flower remedies prepared according to Dr. Bach's Original Method, certified B.A.F.E.P., with WHITE Holographic Bioresonance processing.
- Dermocosmetics: High-quality natural ingredient-based dermocosmetics with derma-restorative, regenerative, and rebalancing properties for sensitive and irritated skin.
- Pet Products (Feed Supplements): Guna4Pets line of complementary feeds for dogs and cats supporting daily nutritional needs and maintenance of normal physiological conditions.
- Publishing: Guna Editore publishes 'La Medicina Biologica' journal and over 50 original texts on complementary medicine topics since 1983.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Products available through pharmacies and healthcare professionals |
Go-to-market motion3 records
Distribution channels6 records
Marketing channels8 records
Guna product offering
Product offeringCore offering
Guna manufactures and distributes low-dose homeopathic medicines, injectable collagen medical devices (Class III), food supplements, Bach flowers, dermocosmetics, and pet nutritional supplements from its pharmaceutical factory in Milan, Italy. The company uses its proprietary SKA (Sequential Kinetic Activation) technology to produce physiological formulations based on Psycho-Neuro-Endocrine-Immunology (PNEI) principles, and distributes its own products plus third-party brands (Heel, Labo'Life, Enterosgel) to over 50 countries through pharmacies and exclusive distributors.
Product overview
Guna is an Italian pharmaceutical company founded in 1983 specializing in low-dose medicine and physiological health products. Its portfolio includes Low Dose Medicine (homeopathic formulations using SKA technology with cytokines, hormones, and neuropeptides), Guna Collagen Medical Devices (13 injectable class III medical devices for pain treatment), Food Supplements (nutraceuticals including probiotics, iron supplements, and botanical formulations), Dermocosmetics (natural skincare), Bach Flowers (emotional therapy preparations), Guna4Pets (animal health supplements), and Publications. The company also distributes third-party brands including Heel (homotoxicology), Labo'Life (micro-immunotherapy), and Enterosgel in Italy. Products are available in over 50 countries through exclusive distributors, with operations in the US under Guna Inc.
Differentiator
Problem solved
Functional benefit
Brands
- Guna4Pets: Complementary feeds (pet food supplements) for dogs and cats of all ages contributing to daily nutritional needs and maintenance of normal physiological conditions of animal friends.
- Guna Collagen Medical Device
- Guna Editore
Products and services
- Low Dose Medicine Homeopathic medicines utilizing low doses of active ingredients derived from plant, mineral, and animal origins, produced via proprietary SKA (Sequential Kinetic Activation) technology. Products include cytokines, hormones, neuropeptides, and growth factors in physiological concentrations for restoring body equilibrium, prescribed by healthcare practitioners for chronic conditions and preventive medicine.
- Guna Collagen Medical Devices Range of 13 Class III CE-marked injectable medical devices containing porcine collagen, indicated for osteo-arthro-myofascial pain treatment and aesthetic medicine applications. Includes MD-Knee, MD-Tissue, MD-Lumbar, MD-Muscle, MD-Neural, and other device variants sold through medical professionals.
- Food Supplements (Nutraceuticals) Physiological nutraceuticals including Proflora (probiotic), Ferroguna (iron supplement), Colostrononi (bovine colostrum), Omega-formula, Epadoguna (liver supplement), and various vitamin and mineral formulations. Sold through pharmacies for consumer health and wellbeing.
- Bach Flowers 38 Bach Flower essence preparations based on Dr. Edward Bach's original method, processed using WHITE Holographic Bioresonance technology for emotional state rebalancing. Includes single remedies and compound formulations distributed through pharmacies for consumer emotional wellness.
- Dermocosmetics Skincare products formulated with natural ingredients including Arnica, Bisabolol, Geranium, Lavender, Neem oil, Peppermint, Tamanu, Tea Tree Oil, and White waterlily for sensitive and irritated skin of face and body. Distributed through pharmacies as part of Guna's product portfolio.
- Guna4Pets (Petformula) Complementary feed supplements for dogs and cats including pastes supporting daily nutritional needs, relaxation, joints, cognitive function, and renal function. Sold through veterinary channels and pharmacies for pet owners seeking natural health support.
- Publications (Guna Editore) Editorial division publishing 'La Medicina Biologica' journal and over 50 original texts on complementary medicine topics including homeopathy, homotoxicology, flower therapy, and biological medicine. Publications carry copyleft license for free distribution.
- Enterosgel (Distributed Product) Intestinal adsorbent medical device distributed in Italy on behalf of Asure Pharma under Bioline license. CE0123 certified product indicated for symptomatic treatment of diarrhea, sold through Italian pharmacy channel.
- Heel Products (Distributed) Homotoxicology medicines distributed exclusively in Italy from Heel, the largest German homotoxicology pharmaceutical company founded by H. H. Reckeweg. Products follow Reckeweg's pathophysiological approach to medicine.
- Labo'Life Products (Distributed) Micro-immunotherapy products developed by Labo'Life (founded in France 1992 by Christian Foissey), distributed exclusively in Italy by Guna. Products focus on optimizing natural immune processes and promoting regulation and self-healing mechanisms.
Quantifiable outcome
- 35% market share in Italian homeopathy sector
- +4 more outcomes
Companies that use Guna
Customer profileNamed customers6 records
Segments4 records
Ideal customer profiles4 records
Guna technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Guna partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered minor and core.
- Zero Impact / LifeGateminorSince 2008, Guna participates in Zero Impact LifeGate project that calculates, reduces, and offsets CO2 emissions from activities, products, services and events. Partnership helps create and protect forests in Costa Rica as part of Guna's environmental sustainability commitment.
- HeelcoreHeel is the largest German homotoxicology pharmaceutical company, founded by H. H. Reckeweg who developed the discipline. Guna is the exclusive distributor of Heel products in Italy. Heel produces homotoxicological medicines following Reckeweg's pathophysiological approach.
- Labo'LifecoreFounded in France in 1992 by Christian Foissey, Labo'Life specializes in micro-immunotherapy. Guna is the exclusive distributor of Labo'Life products in Italy. The company focuses on optimizing natural immune processes and promoting regulation and self-healing mechanisms.
- Asure Pharma (Enterosgel)minorAsure Pharma distributes Enterosgel in Europe under Bioline license. Guna distributes Enterosgel in Italy as a CE0123 medical device for gastrointestinal applications, backed by extensive scientific documentation.
- Italian National Health Institute (Istituto Superiore di Sanita)coreCollaborative research partner conducting basic and clinical research together with Italian and international universities and public entities. Research focus includes low-dose medicines and physiological regulating medicine.
- Fatebenefratelli Hospital, RomecoreCollaborative research partner in clinical studies on low-dose medicine applications and physiological regulating medicine approaches.
- La Sapienza University, RomecoreAcademic research collaboration partner conducting basic and clinical research in low-dose pharmacology and physiological medicine.
- International Academy of Physiological Regulating MedicinecoreProfessional medical academy with which Guna collaborates on research and education in physiological regulating medicine. Part of the permanent scientific committee coordinated by Guna's medical-scientific direction.
- Medical AssociationscorePartnerships with medical associations for organizing educational events, seminars, courses, and multi-year schools for doctors. Guna collaborates with associations dedicated to teaching complementary medicine disciplines.
- Pharmacy AssociationscorePartnerships with pharmacy associations for organizing educational programs and training for pharmacists on low-dose medicines and nutraceuticals.
- International Distributors NetworkcoreExclusive distributors in over 50 countries including: Africa (Egypt, South Africa), Asia/Middle East (Azerbaijan, Georgia, Israel, Jordan, Palestine, Thailand, Vietnam), Europe (Albania, Bulgaria, Croatia, Cyprus, Czech Republic, Greece, Hungary, Ireland, Latvia, Lithuania, Macedonia, Malta, Moldova, Montenegro, Poland, Portugal, Romania, Russia, Slovakia, Slovenia, Spain, Switzerland, Turkey, Ukraine, UK), North America (USA via Guna Inc), Latin America (Bolivia, Chile, Colombia, Ecuador, Guatemala, Peru).
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
Guna competitors and assessment
Company assessmentDirect peers
- Boiron: Boiron is the global leader in homeopathic medicines, headquartered in France. Directly competes with Guna in low-dose and homeopathic product categories across overlapping European and international pharmacy channels, serving the same doctors and pharmacists.
- Biologische Heilmittel Heel: Heel is Germany's leading homotoxicology pharmaceutical company and the originator of Reckeweg's homotoxicology approach. Heel is both a direct competitor in low-dose medicines and a distribution partner whose products Guna distributes exclusively in Italy, making it a close comparable on product, manufacturing, and channel.
- Labo'Life: Labo'Life is a French pharmaceutical company specializing in micro-immunotherapy, founded in 1992. It is both a direct peer in low-dose immunological preparations and a distribution partner distributed exclusively by Guna in Italy, sharing overlapping physician-customer segments and a similar low-dose regulatory pathway.
- Weleda: Weleda is a Swiss-founded manufacturer of anthroposophic and natural medicines, dermocosmetics, and food supplements. Directly comparable to Guna across low-dose medicines, natural skincare, and homeopathic-style formulations, with global pharmacy and practitioner distribution.
- WALA Heilmittel: WALA is a German manufacturer of anthroposophic medicines, natural cosmetics, and holistic remedies. Comparable to Guna in low-dose / potentized pharmaceutical preparations, GMP manufacturing, and practitioner-channel distribution in Europe and select international markets.
- Deutsche Homöopathie-Union (DHU): DHU is the largest German manufacturer of homeopathic medicines, producing a broad range of single remedies and complex preparations. Directly competes with Guna in pharmacy-distributed homeopathic formulations and shares similar European regulatory pathway and practitioner-customer base.
- Schwabe Group: Schwabe is one of the world's largest producers of plant-based and homeopathic pharmaceuticals, headquartered in Germany. Comparable to Guna in low-dose and phytopharmaceutical manufacturing, global pharmacy distribution, and clinical research in botanical medicine.
- A. Vogel (Bioforce): A. Vogel is a Swiss herbal medicine manufacturer producing plant-based pharmaceutical preparations, tinctures, and food supplements. Overlaps with Guna's nutraceutical and natural-medicine lines and shares the European pharmacy distribution model targeting health-conscious consumers.
- Hyland's: Hyland's is a leading US-based homeopathic medicines manufacturer. Directly comparable to Guna in homeopathic product formats, OTC pharmacy distribution, and category leadership, particularly relevant as Guna's US subsidiary (Guna Inc.) competes in the same channel.
Emerging players
- Genexa: Genexa is a US-based homeopathic and clean-label OTC medicines company targeting modern health-conscious consumers. An emerging peer to Guna's homeopathic franchise, sharing the pharmacy/retail channel and increasingly overlapping in clean-label positioning of OTC homeopathic remedies.
Market position
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
Guna social profiles
Digital presenceGuna compliance and trust
Trust signalCompliance6 records
Guna financial estimates
Financial estimateRevenue estimate
Valuation estimate
Guna leadership team
Management profileNumber of profiles
Profiles1 record
Guna subsidiaries and ownership
Company hierarchySubsidiaries1 record
Guna funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Guna M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Guna
What does Guna do?
Guna manufactures and distributes low-dose homeopathic medicines, injectable collagen medical devices (Class III), food supplements, Bach flowers, dermocosmetics, and pet nutritional supplements from its pharmaceutical factory in Milan, Italy. The company uses its proprietary SKA (Sequential Kinetic Activation) technology to produce physiological formulations based on Psycho-Neuro-Endocrine-Immunology (PNEI) principles, and distributes its own products plus third-party brands (Heel, Labo'Life, Enterosgel) to over 50 countries through pharmacies and exclusive distributors.
Is Guna a public or private company?
Guna is a private company. It is classified as family owned and is currently operating.
When was Guna founded?
Guna was founded in 1983. It employs 251 to 500 people.
Where is Guna based?
Guna is headquartered in Milan, Italy, in the Europe region.
How does Guna make money?
Seven revenue lines are on record. Low Dose Medicines are the primary driver. The others are medical Devices, food Supplements (Nutraceuticals), bach Flowers, dermocosmetics, pet Products (Feed Supplements) and publishing.
Who are Guna's main competitors?
Direct peers on record are Boiron, Biologische Heilmittel Heel, Labo'Life, Weleda, WALA Heilmittel, Deutsche Homöopathie-Union (DHU), Schwabe Group, A. Vogel (Bioforce) and Hyland's. Genexa is listed as an emerging player.
Does Guna have an API?
No public API is recorded for Guna.
What industry is Guna in?
Guna's product category is Homeopathic Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIAAAA, Primary Care & General Medicine Pharmaceuticals, with a secondary code of HLAIAAAK, Dermatology & Aesthetics Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.